Sep 25, 2013
Customer Interaction Solutions
Trevi Therapeutics Presents Data at the 7th World Congress on Itch
Nalbuphine is a mixed mu antagonist/kappa agonist opioid. The effect of nalbuphine on substance P induced scratching was studied by Trevi in the mouse model.
Trevi Therapeuitcs Commences Clinical Study of Nalbuphine ER
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! NEW HAVEN, Conn.-- --Trevi Therapeutics, Inc.